Opioids in pain management of mesothelioma and lung cancer patients

Acta Oncologica

Volumn 52, Issue 1, 2013, Pages 30-37

  Salminen, Eeva K ^a   Silvoniemi, Maria ^a   Syrjänen, Karí ^a   Kaasa, Stein ^b,c   Kloke, Marianne ^d   Klepstad, Pål ^c,e  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; ANTIDEPRESSANT AGENT; DEXAMETHASONE; HYPNOTIC AGENT; LAXATIVE; PARACETAMOL;

ADULT; AGED; ANALGESIA; ANXIETY; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; COMPARATIVE STUDY; DEPRESSION; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SELF EVALUATION; SLEEP DISORDER; ADD ON THERAPY; ANOREXIA; ANXIETY DISORDER; BREAKTHROUGH PAIN; CANCER PATIENT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; INSOMNIA; KARNOFSKY PERFORMANCE STATUS; MULTICENTER STUDY; NAUSEA; PAIN SEVERITY; PALLIATIVE THERAPY; TRANSDERMAL PATCH;

ADULT; AGED; ANALGESICS, OPIOID; ANXIETY; CASE-CONTROL STUDIES; COHORT STUDIES; DEPRESSION; EUROPE; FATIGUE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN; PAIN MEASUREMENT; SLEEP DISORDERS;

EID: 84871446657     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.725944     Document Type: Article

References (20)

1. Finnish Cancer Registry 2010.cited February 2012]. Available from: http://www.cancer.fi
2. van Meerbeeck J P, S cherpereel A, S urmont V F, B aas P . Malignant pleural mesothelioma: The standard of care and challenges for future management . Crit Rev Oncol Hematol 2011; 78 : 92 - 111 .
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No . 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010 [cited February 2012]. Available from: http://globocan.iarc.fr
4. Stahel R A, W eder W, L ievens Y, F elip E; ESMO Guidelines Working Group . Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up . Ann Oncol 2010; 21(Suppl 5) : 126 - 8 .
5. Shahin Y, W ellham J, J appie R, P ointon K, M ajewski A, Black E . How successful is lung-preserving radical surgery in the mesothelioma and radical surgery-trial environment? A case-controlled analysis. Eur J Cardiothorac Surg 2011; 39 : 360 - 3 .
6. Van Schil PE, B aas P, G aafar R, M aat A P, V an de Pol M, Hasan B, et al . European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group . Trimodality therapy for malignant pleural mesothelioma: Results from an EORTC phase II multicentre trial. Eur Respir J 2010; 36 : 1362 - 9 .
7. Potter J, H igginson I J. P ain experienced by lung cancer patients: A review of prevalence, causes and pathophysiology . Lung Cancer 2004; 43 : 247 - 57 . (Pubitemid 38224144)
8. Barbera L, S eow H, H owell D, S utradhar R, E arle G, L iu Y, et al . Symptom burden and performance status in a population-based cohort of ambulatory cancer patients . Cancer 2010; 116 : 5767 - 76 .
9. Klepstad P, F ladvad T, S korpen F, B jordal K, C araceni A, Dale O, et al . on behalf of the European Palliative Care Research Collaborative (EPCRC) and the European Association for Palliative Care Research Network . Influence from genetic variability on opioid use for cancer pain. A European genetic association study of 2294 cancer pain patients . Pain 2011;152:1139 - 45.
10. Laugsand E, S prangers M, B jordal K, S korpen F, K aasa S, Klepstad P . Health care providers underestimate symptom intensities of cancer patients: A multicenter European study . Health Qual Life Outcomes 2010; 8 : 104 - 21 .
11. Kaasa S, C herny N, H anks G, d e Conno F and the Research Steering Committee of the EAPC . Pain and pain treatments in European palliative care units . A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med 2005; 19 : 477 - 84 .
12. Karnofsky DA, A berlman WH, C raver LF, B urchenal JH . The use of the nitrogen mustards in the palliative treatment of carcinoma . With particular reference to bronchogenic carcinoma. Cancer 1948; 1 : 634 - 56 .
13. Cordes ME, B rueggen C. D iffuse malignant pleural mesothelioma: Part II . Symptom management. Clin J Oncol Nurs 2003; 7 : 545 - 52 .
14. Muers M F, S tephens R J, F ischer P. A ctive symptoms control with or without chemotherapy in patients with malignant pleural mesothelioma . A multicentrer randomised trial. Lancet 2008; 371 : 1685 - 94 . (Pubitemid 351671885)
15. Waites K, G illigan D. T he role of radiotherapy in the treatment of malignant pleural mesothelioma . Clin Oncol (R Coll Radiol) 2007; 19 : 182 - 7 .
16. Fischer DJ, V illines D, K im YO, E pstein JB, W ilkie DJ . Anxiety, depression, and pain: Differences by primary cancer . Support Care Cancer 2010; 18 : 801 - 10 .
17. Cooley M, S hort T, M oriarty H. S ymptom prevalence, distress and change over time in adults receiving treatment for lung cancer . Psychooncology 2003; 12 : 694 - 708 . (Pubitemid 37236022)
18. Latvala A, S yrj ä nen K, S almenoja H, S alminen E. A naemia and other predictors of fatigue among patients on palliative therapy for advanced cancer . Anticancer Res 2009; 29 : 2569 - 75 .
19. Laugsand E, J acobsen G, K aasa S, K lepstad P. I nadequate symptom control in advanced patients across Europe . Support Care Cancer 2011; 19 : 2005 - 14 .
20. Abrahm JL. P alliative care for the patient with mesothelioma. Semin Thorac Cardiovasc Surg 2009; 21 : 164 - 71 .